SCHEMBL1084012

SCHEMBL1084012

CN(Cc1ccccc1)c1nc(-c2ccccc2O)nc2ccccc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 1/20 0.69
CYP1A2 P05177 8/20 0.56
MAPT P10636 8/20 0.56
CYP3A4 P08684 6/20 0.56
POLB P06746 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
CYP2C9 P11712 1/20 0.56
GBA1 P04062 4/20 0.55
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
RXFP1 Q9HBX9 1/20 0.54
CHEK2 O96017 1/20 0.54
TSHR P16473 9/20 0.53
CYP2D6 P10635 7/20 0.53
CYP2C19 P33261 5/20 0.53
CLK4 Q9HAZ1 4/20 0.53
ALDH1A1 P00352 4/20 0.53
HPGD P15428 2/20 0.52
LMNA P02545 4/20 0.52
KDM4E B2RXH2 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084412 0.86 TSHR (0.58) PDE5ACYP1A2MAPTCYP3A4POLB
SCHEMBL4090908 0.84 CYP1A2 (0.71) PDE5ACYP1A2MAPTCYP3A4POLB
SCHEMBL1084280 0.84 TDP1 (0.62) PDE5ACYP1A2MAPTCYP3A4POLB
SCHEMBL2592281 0.84 PDE5A (0.69) PDE5ACYP1A2MAPTCYP3A4POLB
SCHEMBL1084248 0.84 CHEK2 (0.54) PDE5ACYP1A2MAPTCYP3A4POLB
SCHEMBL1083940 0.84 TSHR (0.50) PDE5ACYP1A2MAPTCYP3A4POLB
SCHEMBL1083829 0.83 CYP2D6 (0.70) PDE5ACYP1A2MAPTCYP3A4POLB
SCHEMBL1084200 0.83 CYP1A2 (0.78) PDE5ACYP1A2MAPTCYP3A4POLB
SCHEMBL8230598 0.83 GBA1 (0.55) PDE5ACYP1A2MAPTCYP3A4POLB
SCHEMBL1084261 0.82 PDE5A (0.47) PDE5ACYP1A2MAPTCYP3A4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed